From: Surgical strategy of bilateral synchronous sporadic renal cell carcinoma—experience of a Chinese university hospital
Characteristics
Number(percentage)
Lost in follow-up
4 (12.5%)
Complications
Clavien I~II
5 (17.9%)
Clavien III
1 (3.6%)
CRI
Hemodialysis
0
Survival
25 (89.3%)
Metastasis/recurrence
1/1 (3.6%/3.6%)